CATALOGO DEI PRODOTTI DELLA RICERCA

SPOSITO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.726
NA - Nord America 1.456
AS - Asia 1.298
SA - Sud America 167
AF - Africa 68
OC - Oceania 7
Totale 4.722
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.399
RU - Federazione Russa 865
SG - Singapore 634
IT - Italia 262
CN - Cina 210
DE - Germania 175
HK - Hong Kong 140
VN - Vietnam 136
BR - Brasile 128
FI - Finlandia 111
GB - Regno Unito 75
FR - Francia 46
CA - Canada 38
IN - India 35
NL - Olanda 33
KR - Corea 31
PL - Polonia 31
IE - Irlanda 26
SE - Svezia 26
ID - Indonesia 24
JP - Giappone 21
ES - Italia 15
TR - Turchia 14
AR - Argentina 13
BJ - Benin 13
TG - Togo 13
AT - Austria 12
BD - Bangladesh 12
UA - Ucraina 12
MX - Messico 11
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
NG - Nigeria 9
VE - Venezuela 8
CO - Colombia 7
AU - Australia 6
EC - Ecuador 6
IQ - Iraq 6
MA - Marocco 6
UZ - Uzbekistan 6
LT - Lituania 5
EG - Egitto 4
BE - Belgio 3
BO - Bolivia 3
CR - Costa Rica 3
KE - Kenya 3
KZ - Kazakistan 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
IL - Israele 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
MK - Macedonia 1
MU - Mauritius 1
RO - Romania 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
WS - Samoa 1
Totale 4.722
Salva come PNG Salva come JPEG
Città #
Singapore 350
Moscow 325
Dallas 268
Ashburn 258
San Jose 209
Hong Kong 139
Munich 128
Verona 90
Helsinki 66
Council Bluffs 55
New York 43
The Dalles 41
Beijing 40
Ho Chi Minh City 37
Los Angeles 36
Chandler 35
Hanoi 34
Milan 28
Dublin 25
London 23
Lappeenranta 19
Tokyo 19
Warsaw 19
Meda 18
São Paulo 18
Buffalo 16
Turku 16
Chicago 15
Montreal 15
Redondo Beach 14
Atlanta 13
Cotonou 13
Lomé 13
Jakarta 12
Nuremberg 11
Orem 11
Santa Clara 11
Brooklyn 10
Da Nang 10
Denver 10
Frankfurt am Main 10
Abuja 9
Amsterdam 9
Barnet 9
Johannesburg 8
Mumbai 8
Stockholm 8
Toronto 8
Trento 8
Belo Horizonte 7
Boardman 7
Columbus 7
Istanbul 7
Manchester 7
Vienna 7
Biên Hòa 6
Boston 6
Chennai 6
Jacksonville 6
Jyväskylä 6
Kyiv 6
Naples 6
New Delhi 6
Turin 6
Washington 6
Isola della Scala 5
Krakow 5
Ottawa 5
Phoenix 5
Poplar 5
Rome 5
San Francisco 5
Tashkent 5
Ann Arbor 4
Baghdad 4
Bussolengo 4
Charlotte 4
Falkenstein 4
Guangzhou 4
Haiphong 4
Houston 4
Maceió 4
Madrid 4
Marseille 4
Paris 4
Piscataway 4
Querétaro 4
Seattle 4
Seoul 4
Shenyang 4
Thái Nguyên 4
Brno 3
Brussels 3
Cairate 3
City of London 3
Cleveland 3
Hangzhou 3
Kebon Manggis 3
Kent 3
Lawrence 3
Totale 2.831
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 307
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 187
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 186
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 174
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 162
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 155
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 154
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 151
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 150
A cross-sectional study exploring the perception of exercise oncology in the Italian population 150
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 149
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 131
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer 130
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 128
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 126
Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers 126
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials 121
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study 121
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study 121
Exercise and bone health in cancer: enemy or ally? 119
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 119
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 114
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report 114
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 108
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 107
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 107
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 100
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 100
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review 90
Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise 90
Overcome the Fear of Exercise in Patients With Bone Metastases: A Qualitative Study on Patients' Perception 90
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer 85
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study 84
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 82
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 74
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates 72
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 66
Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report 39
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 34
Impact of Long-Term Structured Exercise on Body Composition in an NTRK Fusion-Positive NSCLC Patient Treated With Entrectinib 32
Microbiome and EGFR-mutant non-small cell lung cancer: a complex interplay 14
Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity 9
Totale 4.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.420
article - articoli 16.420
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 3 0
2021/202236 1 11 0 0 3 1 1 1 1 2 5 10
2022/2023127 3 11 8 15 6 31 0 15 15 8 8 7
2023/2024279 5 8 19 27 36 31 33 15 10 30 41 24
2024/20251.102 47 24 43 188 27 61 96 73 172 63 115 193
2025/20263.192 154 172 297 575 816 181 312 174 286 225 0 0
Totale 4.778